Search details
1.
SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses.
Cell
; 185(5): 872-880.e3, 2022 03 03.
Article
in English
| MEDLINE | ID: mdl-35123650
2.
Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein.
Cell
; 185(13): 2279-2291.e17, 2022 06 23.
Article
in English
| MEDLINE | ID: mdl-35700730
3.
Tackling COVID-19 with neutralizing monoclonal antibodies.
Cell
; 184(12): 3086-3108, 2021 06 10.
Article
in English
| MEDLINE | ID: mdl-34087172
4.
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.
Cell
; 184(9): 2332-2347.e16, 2021 04 29.
Article
in English
| MEDLINE | ID: mdl-33761326
5.
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines.
Cell
; 184(21): 5432-5447.e16, 2021 10 14.
Article
in English
| MEDLINE | ID: mdl-34619077
6.
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.
Cell
; 181(2): 281-292.e6, 2020 04 16.
Article
in English
| MEDLINE | ID: mdl-32155444
7.
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding.
Cell
; 182(5): 1295-1310.e20, 2020 09 03.
Article
in English
| MEDLINE | ID: mdl-32841599
8.
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
Cell
; 183(4): 1024-1042.e21, 2020 11 12.
Article
in English
| MEDLINE | ID: mdl-32991844
9.
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.
Cell
; 183(5): 1367-1382.e17, 2020 11 25.
Article
in English
| MEDLINE | ID: mdl-33160446
10.
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion.
Cell
; 176(5): 1026-1039.e15, 2019 02 21.
Article
in English
| MEDLINE | ID: mdl-30712865
11.
Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus.
Cell
; 176(6): 1420-1431.e17, 2019 03 07.
Article
in English
| MEDLINE | ID: mdl-30849373
12.
Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans.
Immunity
; 57(4): 904-911.e4, 2024 Apr 09.
Article
in English
| MEDLINE | ID: mdl-38490197
13.
Bifunctional Immunity Proteins Protect Bacteria against FtsZ-Targeting ADP-Ribosylating Toxins.
Cell
; 175(5): 1380-1392.e14, 2018 11 15.
Article
in English
| MEDLINE | ID: mdl-30343895
14.
Tackling COVID-19 with neutralizing monoclonal antibodies.
Cell
; 184(17): 4593-4595, 2021 Aug 19.
Article
in English
| MEDLINE | ID: mdl-34416148
15.
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.
Cell
; 183(6): 1735, 2020 Dec 10.
Article
in English
| MEDLINE | ID: mdl-33306958
16.
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion.
Cell
; 183(6): 1732, 2020 Dec 10.
Article
in English
| MEDLINE | ID: mdl-33306956
17.
Streptomyces umbrella toxin particles block hyphal growth of competing species.
Nature
; 629(8010): 165-173, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38632398
18.
HIV-1 VRC01 Germline-Targeting Immunogens Select Distinct Epitope-Specific B Cell Receptors.
Immunity
; 53(4): 840-851.e6, 2020 10 13.
Article
in English
| MEDLINE | ID: mdl-33053332
19.
ACE2 binding is an ancestral and evolvable trait of sarbecoviruses.
Nature
; 603(7903): 913-918, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35114688
20.
Close relatives of MERS-CoV in bats use ACE2 as their functional receptors.
Nature
; 612(7941): 748-757, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36477529